Kane Biotech Inc. (OTCQB: KNBIF) is a Canadian-based technology company engaged in the development and commercialization of products that prevent and remove microbial biofilms.
Chilean Metals Inc. (OTCQB: CMETF), formerly International PBX Ventures Ltd., is an exploration-stage company. The Company is engaged in exploring copper and gold on its various properties located in Chile and Nova Scotia.
First Cobalt (OTCQB: FTSSF) is focused on building a diversified global portfolio of assets that are highly leveraged to the cobalt market. Our projects include interests proximal to several major copper-cobalt ("Cu-Co") operations in the Central African Copperbelt in the DR Congo - and In Canada, an interest in the former producing Keeley-Frontier mine, a high-grade silver-cobalt mine (produced over 3.3 million pounds of cobalt and 19.1 million ounces of silver 1908 - 1965).
Wize Pharma (OTCQB: WIZPD) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize Pharma has inlicensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of Dry Eye Syndrome, and other ophthalmological illnesses, including Sjorgen's Syndrome and Conjunctivochalasis.